@sahmiedarooie
ارتباط با ادمین در تلگرام @jenabadmin برا عضویت در گروه استعلامات صنعت پخش مدارک داروسازیتون شامل پروانه ی تاسیس و کارت نظام رو برای ادمین بفرستید! سوژه های خبریتون رو هم میتونید بفرستید.
Show more📈 Analytical overview of Telegram channel @sahmiedarooie
Channel @sahmiedarooie (@sahmiedarooie) in the Farsi language segment is an active participant. Currently, the community unites 12 273 subscribers, ranking 2 159 in the Medicine category and 26 129 in the Iran region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 12 273 subscribers.
According to the latest data from 09 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -138 over the last 30 days and by -5 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 33.43%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
- Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.
- Thematic interests: Content is focused on key topics such as داروخانه, تزریق, دارو, آدورا, قرص.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“ارتباط با ادمین در تلگرام
@jenabadmin
برا عضویت در گروه استعلامات صنعت پخش مدارک داروسازیتون شامل پروانه ی تاسیس و کارت نظام رو برای ادمین بفرستید!
سوژه های خبریتون رو هم میتونید بفرستید.”
Thanks to the high frequency of updates (latest data received on 10 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
